The symposium on immune-cell therapy in cancer will be held March 1^st 2018 with the cooperation of the stem cells sciences and technologies development headquarter.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, the symposium on immune-cell therapy in cancer will be held March 1^st 2018 in Shohada Hall of Ahvaz Jundishapur University of Medical Sciences with the cooperation of the stem cells sciences and technologies development headquarter, Ahvaz Jundishapur University of Medical Sciences and cell tech pharmed company.

Areas of this symposium include the latest findings regarding CAR T Cell technology, gene therapy in cancer, treatment using engineered NK cells and treatment using DC cells.

In addition, the workshop of Car T Cell Tehrapy & Introduction to NK will be held February 28^th 2018 in line with the symposium at the location of cancer research center of Ahvaz Jundishapur University of Medical Sciences.

The topics of the event will be introduction of principles of phage display in production of CAR T cells, introduction to the applicable aspects in design and production of CAR T cells, introduction to engineered NK cells in immune-therapy of cancer, and recognition of the latest manipulation methods of NK cells.

The symposium on immune-cell therapy in cancer will be held March 1^st 2018 with the cooperation of the stem cells sciences and technologies development headquarter. Enthusiasts of this field can register for the event by referring to the website of the stem cells science and technology development headquarter.